
Hong Kong-listed Chinese pharma sets sights on SGX for secondary listing
SINGAPORE – A Hong Kong-listed pharmaceutical company is aiming to launch a secondary listing on the Singapore Exchange (SGX) later this month. China Medical System (CMS) filed its preliminary prospectus with the Monetary Authority of Singapore on June 27. …